S&P 500   3,266.78 (+0.62%)
DOW   26,914.43 (+0.37%)
QQQ   268.11 (+1.02%)
AAPL   110.12 (+1.76%)
MSFT   205.95 (+1.36%)
FB   250.54 (+0.40%)
GOOGL   1,423.12 (+0.02%)
AMZN   3,047.34 (+0.91%)
TSLA   404.72 (+4.37%)
NVDA   505.42 (+2.33%)
BABA   267.14 (-0.96%)
CGC   13.98 (-2.03%)
GE   6.03 (-0.50%)
MU   48.17 (-2.63%)
AMD   76.63 (+1.07%)
T   27.78 (-0.93%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.72 (+0.77%)
DIS   122.17 (-0.26%)
BAC   23.22 (-0.51%)
BA   150.54 (+3.07%)
S&P 500   3,266.78 (+0.62%)
DOW   26,914.43 (+0.37%)
QQQ   268.11 (+1.02%)
AAPL   110.12 (+1.76%)
MSFT   205.95 (+1.36%)
FB   250.54 (+0.40%)
GOOGL   1,423.12 (+0.02%)
AMZN   3,047.34 (+0.91%)
TSLA   404.72 (+4.37%)
NVDA   505.42 (+2.33%)
BABA   267.14 (-0.96%)
CGC   13.98 (-2.03%)
GE   6.03 (-0.50%)
MU   48.17 (-2.63%)
AMD   76.63 (+1.07%)
T   27.78 (-0.93%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.72 (+0.77%)
DIS   122.17 (-0.26%)
BAC   23.22 (-0.51%)
BA   150.54 (+3.07%)
S&P 500   3,266.78 (+0.62%)
DOW   26,914.43 (+0.37%)
QQQ   268.11 (+1.02%)
AAPL   110.12 (+1.76%)
MSFT   205.95 (+1.36%)
FB   250.54 (+0.40%)
GOOGL   1,423.12 (+0.02%)
AMZN   3,047.34 (+0.91%)
TSLA   404.72 (+4.37%)
NVDA   505.42 (+2.33%)
BABA   267.14 (-0.96%)
CGC   13.98 (-2.03%)
GE   6.03 (-0.50%)
MU   48.17 (-2.63%)
AMD   76.63 (+1.07%)
T   27.78 (-0.93%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.72 (+0.77%)
DIS   122.17 (-0.26%)
BAC   23.22 (-0.51%)
BA   150.54 (+3.07%)
S&P 500   3,266.78 (+0.62%)
DOW   26,914.43 (+0.37%)
QQQ   268.11 (+1.02%)
AAPL   110.12 (+1.76%)
MSFT   205.95 (+1.36%)
FB   250.54 (+0.40%)
GOOGL   1,423.12 (+0.02%)
AMZN   3,047.34 (+0.91%)
TSLA   404.72 (+4.37%)
NVDA   505.42 (+2.33%)
BABA   267.14 (-0.96%)
CGC   13.98 (-2.03%)
GE   6.03 (-0.50%)
MU   48.17 (-2.63%)
AMD   76.63 (+1.07%)
T   27.78 (-0.93%)
F   6.52 (-2.10%)
ACB   4.99 (-4.04%)
GILD   61.91 (-0.55%)
NFLX   476.72 (+0.77%)
DIS   122.17 (-0.26%)
BAC   23.22 (-0.51%)
BA   150.54 (+3.07%)
Log in
NASDAQ:EDTK

Inozyme Pharma Stock Forecast, Price & News

$3.02
+0.09 (+3.07 %)
(As of 09/25/2020 03:45 AM ET)
Add
Compare
Today's Range
$2.98
Now: $3.02
$3.03
50-Day Range N/A
52-Week Range
$2.90
Now: $3.02
$6.75
Volume509 shs
Average Volume173,864 shs
Market Capitalization$36.24 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Skillful Craftsman Education Technology Limited provides vocational online education and technology services in the People's Republic of China. Its education services cover a range of subjects, including vocational, continuing, and basic education, as well as higher education. The company provides approximately 407 vocational training courses that cover a range of subjects, such as mechanics, electrical, auto repair, and construction. It operates three education platforms, including the Lifelong Education Public Service, Vocational Training, and Virtual Simulation Experimental Training platform to its fee-paying members. The company also offers technology services, including software development and maintenance, hardware installation, and testing and related consulting and training services, as well as cloud services for private companies, academic institutions, and government agencies. Skillful Craftsman Education Technology Limited was founded in 2013 and is headquartered in Wuxi, China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars


Industry, Sector and Symbol

Industry Educational services
Sub-IndustryN/A
Current SymbolNASDAQ:EDTK
CUSIPN/A
CIKN/A
Phone8605-10-8180-5788

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees44
Market Cap$36.24 million
Next Earnings DateN/A
OptionableNot Optionable
$3.02
+0.09 (+3.07 %)
(As of 09/25/2020 03:45 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EDTK News and Ratings via Email

Sign-up to receive the latest news and ratings for EDTK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Inozyme Pharma (NASDAQ:EDTK) Frequently Asked Questions

Who are some of Inozyme Pharma's key competitors?

Who are Inozyme Pharma's key executives?

Inozyme Pharma's management team includes the following people:
  • Mr. Xiaofeng Gao, Founder, Chairman of Directors & CEO (Age 48)
  • Mr. Jun Liu, Chief Financial Officer (Age 43)
  • Mr. Lugang Hua, Chief Technology Officer (Age 47)

When did Inozyme Pharma IPO?

(EDTK) raised $15 million in an IPO on Thursday, July 23rd 2020. The company issued 3,000,000 shares at $4.50-$5.50 per share. The Benchmark Company and Axiom Capital Management, served as the underwriters for the IPO and Prime Number Capital was co-manager.

What is Inozyme Pharma's stock symbol?

Inozyme Pharma trades on the NASDAQ under the ticker symbol "EDTK."

When did the company's quiet period expire?

Inozyme Pharma's quiet period expired on Tuesday, September 1st. Inozyme Pharma had issued 3,000,000 shares in its initial public offering on July 23rd. The total size of the offering was $15,000,000 based on an initial share price of $5.00. During the company's quiet period, insiders and underwriters that worked on the IPO were restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Inozyme Pharma?

Shares of EDTK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Inozyme Pharma's stock price today?

One share of EDTK stock can currently be purchased for approximately $3.02.

How big of a company is Inozyme Pharma?

Inozyme Pharma has a market capitalization of $36.24 million. Inozyme Pharma employs 44 workers across the globe.

What is Inozyme Pharma's official website?

The official website for Inozyme Pharma is www.kingwayup.com.

How can I contact Inozyme Pharma?

Inozyme Pharma's mailing address is FLOOR 4 BLDG 1 NO. 311 YANXIN RD HUISHAN QU, WUXI SHI F4, 214406. The company can be reached via phone at 8605-10-8180-5788.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.